Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Rapamycin Press LLC dba Impact Journals is the publisher of Aging:
www.impactjournals.com
.
Impact Journals is a member of the
Wellcome Trust List of Compliant Publishers
.
Impact Journals is a member of the
Society for Scholarly Publishing
.
Learn about our FREE Post-
Publication Promotion Services
75th Annual Scientific Meeting of the BSRA
NOVA 2026 Recap
Longevity & Aging Series
2025 EPIC Award Winner: Longevity & Aging Series
Editorial
|
Volume 4, Issue 10
|
pp 660—661
Rapamycin as longevity enhancer and cancer preventative agent in the context of p53 deficiency
Lawrence A. Donehower
1
Departments of Molecular Virology & Microbiology, Molecular & Cellular Biology, and Pediatrics, Baylor College of Medicine, Houston, TX 77030
Received:
October 25, 2012
Accepted:
October 26, 2012
Published:
October 27, 2012
https://doi.org/http://dx.doi.org/10.18632/aging.100494
How to Cite
